RNA oxidation in Alzheimer and Parkinson diseases

Journal of Anti-Aging Medicine

Volumn 2, Issue 3, 1999, Pages 227-230

  Nunomura, Akihiko ^a,b   Perry, George ^a   Zhang, Jing ^c   Montine, Thomas J ^c   Takeda, Atsushi ^a   Chiba, Shigeru ^b   Smith, Mark A ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ASAHIKAWA MEDICAL COLLEGE   (Japan)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYGUANINE; REACTIVE OXYGEN METABOLITE; RNA;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; HUMAN; HUMAN TISSUE; NERVE DEGENERATION; NEUROPATHOLOGY; OXIDATION; PARKINSON DISEASE; PRIORITY JOURNAL; RNA TRANSLATION;

EID: 0032718289     PISSN: 10945458     EISSN: None     Source Type: Journal    
DOI: 10.1089/rej.1.1999.2.227     Document Type: Article

References (34)

1. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
2. Yoritaka A, Hattori N, Uchida K, et al. Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease. Proc Natl Acad Sci USA 1996;93:2696-2701.
3. Sayre LM, Zelasko DA, Harris PLR, et al. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 1997;68:2092-2097.
4. Smith MA, Perry G, Richey PL, et al. Oxidative damage in Alzheimer's. Nature 1996;382:120-121.
5. Alam ZI, Daniel SE, Lees AJ, et al. A generalized increase in protein carbonyls in the brain in Parkinson's but not incidental Lewy body disease. J Neurochem 1997;69:1326-1329.
6. Mecocci P, MacGarvey U, Beal MF. Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann Neurol 1994;36:747-751.
7. Alam ZI, Jenner A, Daniel SE, et al. Oxidative DNA damage in the Parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra. J Neurochem 1997;69:1196-1203.
8. Nunomura A, Perry G, Pappolla MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 1999;19:1959-1964.
9. Nunomura A, Perry G, Smith MA. Oxidation of nucleic acids in neurons precedes amyloid β deposition in Down syndrome [Abstract]. J Neuropathol Exp Neurol 1999;58:511.
10. Zhang J, Perry G, Smith MA, et al. Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons. Am J Pathol 1999;154:1423-1429.
11. Yin B, Whyatt RM, Perera FP, et al. Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclonal antibody-based ELISA. Free Radic Biol Med 1995;18:1023-1032.
12. Park EM, Shigenaga MK, Degan P, et al. Assay of excised oxidative DNA lesions: isolation of 8-oxoguanine and its nucleoside derivatives from biological fluids with a monoclonal antibody column. Proc Natl Acad Sci USA 1992;89:3375-3379.
13. Beal MF. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995;38:357-366.
14. Shapira AHV. Mitochondrial disorders. Biochem Biophys Acta 1999;1410:99-102.
15. Joenje H. Genetic toxicology of oxygen. Mutat Res 1989;219:193-208.
16. Takahashi M, Asada K. Superoxide anion permeability of phospholipid membranes and chloroplast thylakoids. Arch Biochem Biophys 1983;226:558-566.
17. Fridovich I. Superoxide dismutases. An adaptation to a paramagnetic gas. J Biol Chem 1989;264:7761-7764.
18. Uppu RM, Cueto R, Squadrito GL, et al. Competitive reactions of peroxynitrite with 2′-deoxyguanosine and 7,8-dihydro-8-oxo-2′-deoxyguanosine (8-oxodG): relevance to the formation of 8-oxodG in DNA exposed to peroxynitrite. Free Radic Biol Med 1996;21: 407-411.
19. Good PF, Perl DP, Bierer LM, et al. Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann Neurol 1992;31:286-292.
20. Smith MA, Harris PLR, Sayre LM, et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-9868.
21. Colton CA, Gilbert DL. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987;223:284-288.
22. Butterfield DA, Hensley K, Harris M, et al. β-Amyloid peptide free radical fragments initiate synaptosomal lipoperoxidation in a sequence-specific fashion: implications to Alzheimer's disease. Biochem Biophys Res Commun 1994;200:710-715.
23. Hensley K, Carney JM, Mattson MP, et al. A model for β-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. Proc Natl Acad Sci USA 1994;91:3270-3274.
24. Smith MA, Taneda S, Richey PL, et al. Advanced Maillard reaction products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 1994;91:5710-5714.
25. Ledesma MD, Bonay P, Colaco C, et al. Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 1994;269: 21614-21619.
26. Yan S-D, Chen X, Schmidt A-M, et al. Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 1994;91:7787-7791.
27. Dani SU. Molecular turnover and aging. In: Dani SU, Hori A, Walter GF, eds. Principles of Neural Aging. Amsterdam: Elsevier, 1997:83-101.
28. Wamer WG, Wei RR: In vitro photooxidation of nucleic acids by ultraviolet A radiation. Photochem Photobiol 1997;65:560-563.
29. Wamer WG, Yin JJ, Wei RR. Oxidative damage to nucleic acids photosensitized by titanium dioxide. Free Radic Biol Med 1997;23:851-858.
30. Fiala ES, Conaway CC, Mathis JE. Oxidative DNA and RNA damage in the livers of Sprague Dawley rats treated with hepatocarcinogen 2-nitropropane. Cancer Res 1989;49:5518-5522.
31. Rhee Y, Valentine MR, Termini J. Oxidative base damage in RNA detected by reverse transcriptase. Nucleic Acids Res 1995;23:3275-3282.
32. Taddei F, Hayakawa H, Bouton M-F, et al. Counter-action by MutT protein of transcriptional errors caused by oxidative damage. Science 1997;278: 128-130.
33. van Leeuwen FW, de Kleijn DPV, van den Hurk HH, et al. Frameshift mutants of β amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients. Science 1998;279:242-247.
34. Lin C-LG, Bristol LA, Jin L, et al. Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis. Neuron 1998;20: 589-602.